September 12, 2025Cancer Epidemiology Biomarkers & Prevention

Molecular reactivity in maternal pregnancy blood and neonatal dried blood spots is associated with risk of pediatric acute lymphoblastic leukemia

View Full Paper

Ask AI

Bookmark

Molecular changes in early life samples are linked to increased risk for pediatric acute lymphoblastic leukemia.
Nine identified molecular changes in neonatal samples showed stronger association with leukemia than 16 in maternal serum.
Direct measurement methods like metabolomics and the Reactomics approach were used to analyze blood samples.
Findings imply the need for further investigation of molecular reactivity in early life as potential biomarkers for leukemia.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Nested case-control study identifies molecular signatures in maternal and neonatal samples, suggesting risks for pediatric acute lymphoblastic leukemia.

Cite This Study

Petrick et al. (2025) studied this question.

synapsesocial.com/papers/68d41c02713b0b5dfea65461 https://doi.org/10.1158/1055-9965.epi-25-0801

View Full Paper

Ask AI

Bookmark

Implication

Nested case-control study identifies molecular signatures in maternal and neonatal samples, suggesting risks for pediatric acute lymphoblastic leukemia.

Molecular reactivity in maternal pregnancy blood and neonatal dried blood spots is associated with risk of pediatric acute lymphoblastic leukemia

Key Points

Discussion

Implication

Cite This Study

Molecular reactivity in maternal pregnancy blood and neonatal dried blood spots is associated with risk of pediatric acute lymphoblastic leukemia

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider